Devices & Diagnostics

10th Annual MedTech Investing Conference convenes in Minneapolis on May 19

This post is sponsored by International Business Forum. On May 19th, IBF International Business Forum and LifeScience Alley present the 10th annual MedTech Investing Conference.  To mark this decade, the conference will focus on the “New Era of Innovation” providing attendees with insight on the radically changing dynamics and regulatory issues in the United States […]

This post is sponsored by International Business Forum.

On May 19th, IBF International Business Forum and LifeScience Alley present the 10th annual MedTech Investing Conference.  To mark this decade, the conference will focus on the “New Era of Innovation” providing attendees with insight on the radically changing dynamics and regulatory issues in the United States and globally.

A recent study by PwC entitled, “Medical Technology Innovation Scorecard” will set the stage for the conference by revealing who is competing in the race for global leadership by assessing nine countries’ capacity and capability for medical technology innovation.

The innovation ecosystem for medical device technology, long centered in the United States, is moving offshore.  Increasingly, medical technology innovators are going outside the U.S. to seek clinical data, new-product registration, and first revenue.  Dan Schultz, MD, former Director of the Center for Devices and Radiological Health at FDA and Richard Baer, MD, formerly the Lead Medical Director for National Government Services, will address how the design of a clinical study can meet both the FDA and CMS’ requirements to ensure expedited approval and a positive coverage and payment plan.

Traditionally, VCs have funded technologies that are then built into stand alone companies giving them multiple exit options.   As big caps continue to have an appetite to acquire new innovative medical devices, the option to build a self sustaining company is becoming less compelling.  With increased capital requirements and regulatory timelines, the conference will explore the pros and cons of the traditional model vs. developing product extension companies out of the gate.  Will the “build to flip” model yield better risk/reward ratios? 

Join your peers and future business partners at this annual conference to gain an in-depth understanding of a radically changing medical device market.  For more information on the agenda, confirmed speakers and sponsors visit www.medtechconference.com.

This post appears through the MedCity Influencers program. Anyone can publish their perspective on business and innovation in healthcare on MedCity News through MedCity Influencers. Click here to find out how.

Topics